ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ARWR Arrowhead Pharmaceuticals Inc

22.04
0.17 (0.78%)
Last Updated: 15:35:03
Delayed by 15 minutes

Period:

Draw Mode:

Volume 346,478
Bid Price 22.03
Ask Price 22.05
News -
Day High 22.36

Low
20.67

52 Week Range

High
42.48

Day Low 21.72
Company Name Stock Ticker Symbol Market Type
Arrowhead Pharmaceuticals Inc ARWR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.17 0.78% 22.04 15:35:03
Open Price Low Price High Price Close Price Prev Close
22.12 21.72 22.36 21.87
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
7,541 346,478 $ 22.13 $ 7,667,932 - 20.67 - 42.48
Last Trade Time Type Quantity Stock Price Currency
15:35:03 2 $ 22.04 USD

Arrowhead Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.73B 123.90M - 240.74M -205.28M -1.66 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Arrowhead Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ARWR Message Board. Create One! See More Posts on ARWR Message Board See More Message Board Posts

Historical ARWR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week22.5224.6821.3923.03930,167-0.48-2.13%
1 Month28.2528.50521.3924.46885,162-6.21-21.98%
3 Months31.5236.7221.3929.561,301,546-9.48-30.08%
6 Months23.9839.8320.6729.691,408,741-1.94-8.09%
1 Year34.0042.4820.6730.611,181,959-11.96-35.18%
3 Years72.0093.6620.6739.95941,130-49.96-69.39%
5 Years19.0993.6617.2542.321,148,5872.9515.45%

Arrowhead Pharmaceuticals Description

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Your Recent History

Delayed Upgrade Clock